Close
 Indian J Med Microbiol  
 

Figure 4 (A-D): Complete response following TACE in a patient of small HCC with chronic hepatitis B (BCLC-B). Pre-TACE arterial phase CT scan (A) shows a large enhancing surface tumor (arrow) in segment 6 of the liver. TACE was done. Post-TACE CT scan at 1 month (B) shows Lipiodol completely involving the tumor (arrow), with no enhancing residual viable tumor. Follow-up CT scans at 1 year (C) and 3 years (D), respectively, show marked tumor shrinkage, with retained Lipiodol and no residual or recurrent disease

Figure 4 (A-D): Complete response following TACE in a patient of small HCC with chronic hepatitis B (BCLC-B). Pre-TACE arterial phase CT scan (A) shows a large enhancing surface tumor (arrow) in segment 6 of the liver. TACE was done. Post-TACE CT scan at 1 month (B) shows Lipiodol completely involving the tumor (arrow), with no enhancing residual viable tumor. Follow-up CT scans at 1 year (C) and 3 years (D), respectively, show marked tumor shrinkage, with retained Lipiodol and no residual or recurrent disease